Home / Health / Beyond Prices: Fixing India's Health Crisis
Beyond Prices: Fixing India's Health Crisis
18 Oct
Summary
- Hospitals charge vastly different amounts for similar treatments.
- Govt caps cancer medicine trade margins at 30%.
- Price controls alone don't solve deeper healthcare issues.
Modern healthcare economics often result in significant price disparities between hospitals for the same treatments. A procedure costing Rs 1 lakh in one facility might reach Rs 3 lakh elsewhere, despite similar medical protocols. This discrepancy raises questions about whether patient bills reflect genuine needs.
The government's recent decision to cap trade margins on cancer medicines at 30% offers financial relief for families facing costly treatments. However, this measure addresses only one facet of a larger problem. India's healthcare system grapples with issues beyond drug pricing, including over-prescription, excessive tests, and costly procedures of questionable benefit.
Previous price control attempts, such as reductions in coronary stent and knee implant prices, did not always translate into proportional overall cost savings for patients. Hospitals may offset lower component costs by increasing charges elsewhere. Therefore, focusing solely on prices risks overlooking the necessity and appropriateness of prescribed treatments.
Effective healthcare requires more than just affordability; quality and availability are equally crucial. Substandard or falsified medical products pose a significant risk, especially in critical treatments like cancer care. Strengthening manufacturing oversight and regulatory enforcement is vital to ensure patient safety and treatment efficacy.
The ultimate goal is to make the entire episode of care accountable. This involves transparent treatment packages, itemized bills, evidence-based prescribing, and payment systems that reward outcomes. Healthcare should prioritize patient health and well-being over commercial incentives or procedural volume.
